IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 14 filers reported holding IMMUNOMEDICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $703,000 | -28.4% | 250,000 | -53.3% | 0.02% | -32.4% |
| Q2 2017 | $982,000 | +30.8% | 535,000 | 0.0% | 0.04% | +27.6% |
| Q1 2017 | $751,000 | +42.0% | 535,000 | 0.0% | 0.03% | +45.0% |
| Q4 2016 | $529,000 | +11.4% | 535,000 | 0.0% | 0.02% | +17.6% |
| Q3 2016 | $475,000 | +19.3% | 535,000 | -6.1% | 0.02% | +21.4% |
| Q2 2016 | $398,000 | -62.1% | 570,000 | -63.7% | 0.01% | -58.8% |
| Q1 2016 | $1,051,000 | – | 1,570,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Graham Capital Management, L.P. | 17,594,000 | $51,944,000 | 1.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 3,950,000 | $11,618,000 | 0.15% |
| Jefferies Group LLC | 3,889,000 | $11,591,000 | 0.06% |
| Calamos Advisors LLC | 2,500,000 | $7,324,000 | 0.05% |
| AMERIPRISE FINANCIAL INC | 1,000,000 | $2,950,000 | 0.00% |